nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN8A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0425	0.0805	CbGpPWpGaD
Mepivacaine—SCN9A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0343	0.0651	CbGpPWpGaD
Mepivacaine—SCN3A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0328	0.0622	CbGpPWpGaD
Mepivacaine—SCN2A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0316	0.0598	CbGpPWpGaD
Mepivacaine—SCN4A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0316	0.0598	CbGpPWpGaD
Mepivacaine—SCN1A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0304	0.0577	CbGpPWpGaD
Mepivacaine—SCN10A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0304	0.0577	CbGpPWpGaD
Mepivacaine—SCN8A—forebrain—attention deficit hyperactivity disorder	0.0301	0.0637	CbGeAlD
Mepivacaine—SCN1A—forebrain—attention deficit hyperactivity disorder	0.0228	0.0482	CbGeAlD
Mepivacaine—SCN5A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0214	0.0405	CbGpPWpGaD
Mepivacaine—SCN2A—forebrain—attention deficit hyperactivity disorder	0.0209	0.0442	CbGeAlD
Mepivacaine—SCN10A—forebrain—attention deficit hyperactivity disorder	0.0201	0.0426	CbGeAlD
Mepivacaine—SCN3A—forebrain—attention deficit hyperactivity disorder	0.0184	0.0389	CbGeAlD
Mepivacaine—SCN9A—midbrain—attention deficit hyperactivity disorder	0.0175	0.037	CbGeAlD
Mepivacaine—SCN8A—nervous system—attention deficit hyperactivity disorder	0.0163	0.0346	CbGeAlD
Mepivacaine—SCN8A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.0163	0.0309	CbGpPWpGaD
Mepivacaine—SCN8A—central nervous system—attention deficit hyperactivity disorder	0.0157	0.0333	CbGeAlD
Mepivacaine—SCN5A—cardiovascular system—attention deficit hyperactivity disorder	0.0155	0.0328	CbGeAlD
Mepivacaine—SCN8A—cerebellum—attention deficit hyperactivity disorder	0.0154	0.0326	CbGeAlD
Mepivacaine—SCN1A—midbrain—attention deficit hyperactivity disorder	0.015	0.0318	CbGeAlD
Mepivacaine—SCN2A—midbrain—attention deficit hyperactivity disorder	0.0138	0.0292	CbGeAlD
Mepivacaine—SCN9A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.0132	0.025	CbGpPWpGaD
Mepivacaine—SCN4A—nervous system—attention deficit hyperactivity disorder	0.0128	0.0271	CbGeAlD
Mepivacaine—SCN3A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.0126	0.0239	CbGpPWpGaD
Mepivacaine—SCN8A—brain—attention deficit hyperactivity disorder	0.0125	0.0264	CbGeAlD
Mepivacaine—SCN1A—nervous system—attention deficit hyperactivity disorder	0.0124	0.0262	CbGeAlD
Mepivacaine—SCN4A—central nervous system—attention deficit hyperactivity disorder	0.0123	0.0261	CbGeAlD
Mepivacaine—SCN3A—midbrain—attention deficit hyperactivity disorder	0.0121	0.0257	CbGeAlD
Mepivacaine—SCN4A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.0121	0.0229	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.0121	0.0229	CbGpPWpGaD
Mepivacaine—SCN1A—central nervous system—attention deficit hyperactivity disorder	0.0119	0.0252	CbGeAlD
Mepivacaine—SCN1A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.0117	0.0221	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.0117	0.0221	CbGpPWpGaD
Mepivacaine—SCN1A—cerebellum—attention deficit hyperactivity disorder	0.0116	0.0246	CbGeAlD
Mepivacaine—SCN2A—nervous system—attention deficit hyperactivity disorder	0.0113	0.024	CbGeAlD
Mepivacaine—SCN9A—brain—attention deficit hyperactivity disorder	0.011	0.0232	CbGeAlD
Mepivacaine—SCN10A—nervous system—attention deficit hyperactivity disorder	0.0109	0.0231	CbGeAlD
Mepivacaine—SCN2A—central nervous system—attention deficit hyperactivity disorder	0.0109	0.0231	CbGeAlD
Mepivacaine—SCN2A—cerebellum—attention deficit hyperactivity disorder	0.0107	0.0226	CbGeAlD
Mepivacaine—SCN10A—central nervous system—attention deficit hyperactivity disorder	0.0105	0.0223	CbGeAlD
Mepivacaine—SCN3A—nervous system—attention deficit hyperactivity disorder	0.00996	0.0211	CbGeAlD
Mepivacaine—SCN5A—nervous system—attention deficit hyperactivity disorder	0.00993	0.021	CbGeAlD
Mepivacaine—SCN4A—brain—attention deficit hyperactivity disorder	0.00979	0.0207	CbGeAlD
Mepivacaine—SCN3A—central nervous system—attention deficit hyperactivity disorder	0.00959	0.0203	CbGeAlD
Mepivacaine—SCN5A—central nervous system—attention deficit hyperactivity disorder	0.00956	0.0203	CbGeAlD
Mepivacaine—SCN1A—brain—attention deficit hyperactivity disorder	0.00944	0.02	CbGeAlD
Mepivacaine—SCN3A—cerebellum—attention deficit hyperactivity disorder	0.00938	0.0199	CbGeAlD
Mepivacaine—SCN2A—brain—attention deficit hyperactivity disorder	0.00867	0.0183	CbGeAlD
Mepivacaine—SCN10A—brain—attention deficit hyperactivity disorder	0.00836	0.0177	CbGeAlD
Mepivacaine—SCN5A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.00821	0.0156	CbGpPWpGaD
Mepivacaine—SCN3A—brain—attention deficit hyperactivity disorder	0.00762	0.0161	CbGeAlD
Mepivacaine—SCN5A—brain—attention deficit hyperactivity disorder	0.00759	0.0161	CbGeAlD
Mepivacaine—SCN8A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00616	0.0117	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00498	0.00944	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00476	0.00903	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00458	0.00867	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00458	0.00867	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00441	0.00836	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00441	0.00836	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00439	0.00833	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00434	0.00822	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00397	0.00752	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00392	0.00743	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00355	0.00673	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00351	0.00665	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.0034	0.00644	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00337	0.00639	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00336	0.00636	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00327	0.00619	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00327	0.00619	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00322	0.00611	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00322	0.00611	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00321	0.00608	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00315	0.00597	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00315	0.00597	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00314	0.00594	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00314	0.00594	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00311	0.00589	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00311	0.00589	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.0031	0.00588	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.0031	0.00587	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00307	0.00582	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00295	0.00559	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00295	0.00559	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00284	0.00539	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00284	0.00539	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00283	0.00537	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.0025	0.00474	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.0024	0.00454	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00236	0.00447	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.0023	0.00436	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.0023	0.00436	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00229	0.00434	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00228	0.00431	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00222	0.0042	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00222	0.0042	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00221	0.0042	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00219	0.00415	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00219	0.00414	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.0021	0.00399	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.0021	0.00399	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00203	0.00385	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00203	0.00385	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.002	0.00379	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00192	0.00365	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00156	0.00296	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00143	0.0027	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00102	0.00193	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000804	0.00152	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000651	0.00123	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000622	0.00118	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000598	0.00113	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000598	0.00113	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000576	0.00109	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000576	0.00109	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000405	0.000768	CbGpPWpGaD
